Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)

Background: Epilepsy is one of the most common symptoms of brain tumors. It is often drug resistant and generally worsen patients' quality of life (QoL). Brain tumors release glutamate among other mediators, contributing to seizures onset, and this is accompanied by an increased AMPA receptors&...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Front Neurol
Κύριοι συγγραφείς: Coppola, Antonietta, Zarabla, Alessia, Maialetti, Andrea, Villani, Veronica, Koudriavtseva, Tatiana, Russo, Emilio, Nozzolillo, Agostino, Sueri, Chiara, Belcastro, Vincenzo, Balestrini, Simona, Ferlazzo, Edoardo, Giannarelli, Diana, Bilo, Leonilda, Maschio, Marta
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Frontiers Media S.A. 2020
Θέματα:
Neurology
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336340/
https://ncbi.nlm.nih.gov/pubmed/32695064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00592
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια